Adjudicatario
Exeltis Germany GmbH
Ismaning · DEU
Adjudicaciones
34
Importe total adjudicado
2,3 M €
29 adjudicación(es) conjunta(s) contada(s) a prorrata
Órganos de contratación
5
Sectores
1
USt-IdNr. DE270418798
Contratos de este adjudicatario próximos a vencer
- —
17 abr 2027
estimada - —
17 abr 2027
estimada 31 dic 2027
declarada075 | Desogestrel Filmtabletten [2]46.392 €IKK classicExeltis Germany GmbH, Gedeon Richter Plc. vertreten durch Gedeon Richter Pharma GmbH
- 185.739 €
31 dic 2027
declarada 31 dic 2027
declarada083 | Dienogest Tabletten u.w. [3]147.023 €IKK classicExeltis Germany GmbH, Gedeon Richter Plc. vertreten durch Gedeon Richter Pharma GmbH, Hormosan Pharma GmbH
- 1.642.475 €
31 dic 2027
declarada 31 mar 2028
declaradaEtonogestrel und Ethinylestradiol - TK, hkk, HEK (ATC-Code: G02BB01)—Techniker KrankenkasseExeltis Germany GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - TK, hkk, HEK (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - Barmer (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - DAK-G, KKH (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - TK, hkk, HEK (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - Barmer (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
31 mar 2028
declaradaDesogestrel FTA - DAK-G, KKH (ATC-Code: G03AC09)—Techniker KrankenkasseExeltis Germany GmbH, Gedeon Richter GmbH, Hormosan Pharma GmbH
30 sept 2028
declaradaEtonogestrel + Ethinylestradiol - BARMER—BARMER Beschaffung und VergabeAristo Pharma GmbH, Exeltis Germany GmbH
30 sept 2028
declaradaEtonogestrel + Ethinylestradiol - DAK-G, KKH—BARMER Beschaffung und VergabeAristo Pharma GmbH, Exeltis Germany GmbH
- —
30 sept 2028
declarada - —
30 sept 2028
declarada - 323.662 €
31 dic 2028
declarada - 141.550 €
31 dic 2028
declarada - 323.662 €
31 dic 2028
declarada - 141.550 €
31 dic 2028
declarada - 10 €RV
31 dic 2028
declarada - 10 €RV
31 dic 2028
declarada 31 dic 2028
declaradaChlormadinon + Ethinylestradiol (FTA)—GWQ ServicePlus AGExeltis Germany GmbH, HEXAL AG, PUREN Pharma GmbH & Co. KG
31 dic 2028
declaradaLevonorgestrel + Ethinylestradiol (FTA)—GWQ ServicePlus AGExeltis Germany GmbH, Hormosan Pharma GmbH, ratiopharm GmbH
Todos los contratos próximos a vencer →